EMEA-001495-PIP02-21
Key facts
| Active substance |
drospirenone
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0451/2021
|
| PIP number |
EMEA-001495-PIP02-21
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of endometriosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Chemo Research, S.L.
Email: Barbara.Herranz@exeltis.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|